51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000031572	2020-05-01	2020-04-04	A randomized controlled clinical study on the efficacy and safety of erbium laser percutaneous methotrexate in the treatment of localized scleroderma	A randomized controlled clinical study on the efficacy and safety of erbium laser percutaneous methotrexate in the treatment of localized scleroderma	morphea	control group:Erbium laser;experimental group:erbium laser assisted delivery of methotrexate;	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	NULL	Recruiting	18	65	Both	control group:28;experimental group:28;		China
2	NCT02339441 (ClinicalTrials.gov)	June 2010	22/12/2014	Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis	Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis	Early Diffuse Cutaneous Systemic Sclerosis	Drug: Methotrexate;Drug: Mycophenolate mofetil;Drug: Cyclophosphamide	University of Manchester	NULL	Completed	18 Years	N/A	Both	320	N/A	NULL
3	NCT00241189 (ClinicalTrials.gov)	August 2002	14/10/2005	Rapamycin vs Methotrexate in Diffuse SSc	A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)	Systemic Sclerosis	Drug: rapamycin;Drug: methotrexate	University of California, Los Angeles	NULL	Completed	18 Years	70 Years	Both	17	Phase 1/Phase 2	United States